Alerts

Identify biomarker results as they become available not weeks later

CommercializationMedical Affairs

hero anchor
ODS Alerts

NeoGenomics Alerts deliver real-time, HCP-level trigger signals directly from our lab. The same lab that ran the test. No claims lag, no extrapolation. Just direct diagnostic signal at the moment it matters. 

89K+
 
US Ordering and treating providers

Alerts are configurable to your biomarker, tumor type, and engagement rules and designed to work with both commercial and scientific teams.

CommercializationField team trigger signals

Notify field representatives the moment a relevant biomarker result is generated at a provider in their territory — before a claims feed could surface the same information.

  • Configurable by biomarker, tumor type, geography, and HCP
  • Delivered via CRM integration or direct data feed
  • Non-promotional framing by design supports appropriate engagement rules

Medical AffairsScientific exchange timing

Surface the moment an HCP orders a biomarker relevant to your therapeutic area, enabling MSL engagement timed to the point of clinical decision-making.

  • Biomarker-specific trigger logic suited for non-promotional education
  • Identification of HCPs newly ordering relevant tests
  • Supports HEOR and evidence generation program targeting

Testing Gap IdentificationFind where diagnosis outpaces testing

Identify patients diagnosed with a tumor type where the relevant biomarker test has not been ordered - a gap that represents both clinical opportunity and commercial program focus.

  • Flags accounts where guideline-recommended testing is lagging
  • Supports education and testing awareness programs
  • Quantifies the untested population in your target geography

Concordance AnalysisTest result to therapy selection

Track the relationship between biomarker test results and subsequent therapy selection, identifying where positive results are not translating into targeted treatment decisions.

  • Configurable by biomarker, tumor type, geography, and HCP
  • Delivered via CRM integration or direct data feed
  • Non-promotional framing by design supports appropriate engagement rules

How it works

From test order to alert delivery in just four steps, zero claims intermediary.

Step 1

Test ordered at NeoGenomics

An HCP sends a sample to our lab for biomarker testing — PD-L1, EGFR, HER2, or any configured biomarker.

PD-L1 EGFR HER2 Any configured biomarker
Step 2

Results are generated

NeoGenomics runs the test and generates a result directly from the specimen. No extrapolation, no modeling.

No modeling No extrapolation Directly from the specimen
Step 3

Alert is triggered

If the result matches your configured criteria (which can include clinical data such as prior therapy, stage, etc.), an alert is generated instantly — the same day the result is available.

Same-day alerts

Prior therapy Stage Other clinical data
Step 4

Delivered to your team

Alerts reach your field team via CRM integration, secure data feed, or dashboard — in time to act, not in time to look back.

CRM Integration Dashboard Secure data feed

See what alerts look like for your indication

Get in touch

Please contact our Oncology Data Solutions team: oncologydatasolutions@neogenomics.com

If you need assistance with your client portal login (NeoLink), please contact Client Services at Client.Services@neogenomics.com or call us at 866.776.5907, Option 3.

Alerts | NeoGenomics Laboratories